These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19157769)

  • 1. Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon.
    Zahwe M; El Sammak A; Ataya K; Jabbour C; Bsat A; Hafez B; Atallah C; Kheil M; Maktabi MA; Hassan B; Panossian V; Assi H; Abbas J; Sbaity E
    Cancer Med; 2024 Jan; 13(1):e6868. PubMed ID: 38133150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy with carbon nanoparticle suspension after neoadjuvant chemotherapy for breast cancer patients.
    Wei N; Hou J; Chen J; Dai M; Du K; Wang S; Ni Q
    Ann R Coll Surg Engl; 2021 Nov; 103(10):752-756. PubMed ID: 34448655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients Who Become Clinically Node-Negative Following Neo-Adjuvant Chemotherapy: A Literature Review.
    Ferrarazzo G; Nieri A; Firpo E; Rattaro A; Mignone A; Guasone F; Manzara A; Perniciaro G; Spinaci S
    Curr Oncol; 2023 Sep; 30(10):8703-8719. PubMed ID: 37887530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to "Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate.
    Munck F; Kroman NT; Tvedskov THF
    Ann Surg Oncol; 2024 Jan; 31(1):400. PubMed ID: 37932599
    [No Abstract]   [Full Text] [Related]  

  • 5. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
    Kuehn T; Bauerfeind I; Fehm T; Fleige B; Hausschild M; Helms G; Lebeau A; Liedtke C; von Minckwitz G; Nekljudova V; Schmatloch S; Schrenk P; Staebler A; Untch M
    Lancet Oncol; 2013 Jun; 14(7):609-18. PubMed ID: 23683750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study.
    Houvenaeghel G; de Nonneville A; Cohen M; Viret F; Rua S; Sabiani L; Buttarelli M; Charaffe E; Monneur A; Jalaguier-Coudray A; Bannier M; Sabatier R; Gonçalves A
    J Surg Res (Houst); 2022; 5(3):511-525. PubMed ID: 36714356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
    Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
    Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph nodes for breast carcinoma: an update on current practice.
    Maguire A; Brogi E
    Histopathology; 2016 Jan; 68(1):152-67. PubMed ID: 26768036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and axilla sparing potentials of sentinel lymph node biopsy with methylene blue alone performed before versus after neoadjuvant chemotherapy in breast cancer: a single institution experience.
    Zhang GC; Liao N; Guo ZB; Qian XK; Ren CY; Yao M; Li XR; Wang K; Zu J
    Clin Transl Oncol; 2013 Jan; 15(1):79-84. PubMed ID: 22926944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy before versus after neoadjuvant chemotherapy for breast cancer.
    Shimazu K; Noguchi S
    Surg Today; 2011 Mar; 41(3):311-6. PubMed ID: 21365408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
    Catzeddu T; Bertelli G; Del Mastro L; Venturini M
    J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of sentinel lymph node biopsy in the management of breast cancer.
    Khan A; Vohra P; Quinlan RF
    Indian J Pathol Microbiol; 2007 Apr; 50(2):261-9. PubMed ID: 17883042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymphadenectomy for the staging of clinical axillary node-negative breast cancer before neoadjuvant chemotherapy.
    Menard JP; Extra JM; Jacquemier J; Buttarelli M; Lambaudie E; Bannier M; Brenot Rossi I; Houvenaeghel G
    Eur J Surg Oncol; 2009 Sep; 35(9):916-20. PubMed ID: 19157769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.